Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilator Test in Mechanically Ventilated COPD
NCT02218398Unknown
- Sponsor
- Beijing Chaoyang Hospital
- Start
- May 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of salbutamol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: Percentage of 12% Decrease in airway resistance at 30 minutes. Status: unknown.
02
Drugs
salbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02218398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218398.